Error: Could not add to watchlist. X

Medistem Inc

+ Watchlist
MEDS:US
Acquired
MEDS:US was acquired by 2861701Z:US
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding (m)
14.285
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Medistem, Inc. conducts business in the clinical application of adult stem cell treatments on a fee-for-services basis. The Company has acquired intellectual property in the application of non-controversial adult stem cells in certain medical treatments.
ADDRESS
2223 West Pecos Road
Suite 6
Chandler, AZ 85224
United States
PHONE
1-877-372-7836
  • Vladimir Bogin
    Chairman
  • Vladimir Zaharchook
    Vice Chairman
  • John P Salvador
    Chief Operating Officer
  • Sergey Sablin
    Vice President
  • Erik J Woods
    VP:Manufacturing
Show More